Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder
This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participants will complete a 12-week course of study treatment including two psilocybin sessions with psychological support, and follow-up assessments 3 and 6 months after the first psilocybin session.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Johns Hopkins University
- Principal investigator
- Albert Garcia-Romeu, Ph.D.
- Start date
- 2024-11-08
- End date
- 2026-12-01
- Registry ID
- NCT06660381
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.